Clinical Trial Update: A Potential Novel Marker for Liver Fibrosis in NASH: the Soluble Secreted Form of the Human Asialoglycoprotein Receptor

View source ↗

Summary

A completed clinical trial evaluated the soluble secreted form of the human asialoglycoprotein receptor as a potential biomarker for liver fibrosis in non-alcoh…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Fibrosis
• Non-alcoholic Steatohepatitis

Snippet

Sponsor: Ziv Hospital | Conditions: Liver Fibrosis | Status: COMPLETED